Judgment of the Court (Second Chamber) of 21 April 2005.

Novartis AG, University College London and Institute of Microbiology and Epidemiology v Comptroller-General of Patents, Designs and Trade Marks for the United Kingdom (C-207/03) and Ministre de l'Économie v Millennium Pharmaceuticals Inc. (C-252/03).

References for a preliminary ruling: High Court of Justice (England & Wales), Chancery Division (Patents Court) - United Kingdom and Cour administrative - Luxembourg.

Patent law - Medicinal products - Supplementary protection certificate for medicinal products.

Joined cases C-207/03 and C-252/03.


Top of the page Documents in the Case
Document Date Name of the parties Subject-matter Curia EUR-Lex
Judgment (OJ)
11/06/2005 Novartis and Others
View pdf documents
Judgment
ECLI:EU:C:2005:245
21/04/2005 Novartis and Others
EUR-Lex text EUR-Lex bilingual text
Judgment (Summary)
ECLI:EU:C:2005:245
21/04/2005 Novartis and Others
Opinion
ECLI:EU:C:2004:491
07/09/2004 Novartis and Others
EUR-Lex text EUR-Lex bilingual text
Application (OJ)
05/07/2003 Novartis and Others
View pdf documents
Top of the page Legal analysis of the decision or of the case

Reports of Cases

2005 I-03209

Subject-matter

Preliminary ruling - High Court of Justice of England and Wales - Interpretation of Article 13 of Council Regulation No 1768/92 of 18 June 1992 (as amended by the EEA Agreement) concerning the creation of a supplementary protection certificate for medicinal products – Medicinal products which obtained marketing authorisation in Switzerland (authorisation automatically recognised by Liechtenstein) a number of months prior to receiving marketing authorisation within the Community – Date to be taken into account for the purpose of calculating the duration of the supplementary protection certificate

Systematic classification scheme

1.
B European Community (EEC/EC)
  B-11 Approximation of laws and uniform laws
    B-11.02 Uniform laws
      B-11.02.01 Supplementary protection certificate for medicinal products


Citations of case-law or legislation

References in grounds of judgment

  • Agreement on the European Economic Area -A07 : paragraph 6
  • Agreement on the European Economic Area -A126 : paragraph 10
  • Agreement on the European Economic Area -N2 : paragraphs 11, 28, 30
  • Agreement on the European Economic Area -N2CH13 : paragraph 7
  • Agreement on the European Economic Area -N17PT6 : paragraph 5
  • Agreement on the European Economic Area - Protocol No 1 -PT8 : paragraph 9
  • Directive 65/65 : paragraphs 28, 29, 32
  • Court of Justice - Rules of Procedure (1991) -A43 : paragraph 25
  • Court of Justice - Rules of Procedure (1991) -A103 : paragraph 25
  • Regulation 1768/92 : paragraph 2
  • Regulation 1768/92 -A03 : paragraph 4
  • Regulation 1768/92 -A13 : paragraphs 1, 8, 17, 24, 26, 27, 30 - 34
  • Regulation 1768/92 -C8 : paragraphs 3, 31
  • Regulation 1768/92 -C9 : paragraph 3

Operative part

  • Interprets : Regulation 1768/92 -A13
  • Interprets : Agreement on the European Economic Area

Opinion


Dates

Date of the lodging of the application initiating proceedings

  • 14/05/2003

Date of the Opinion

  • 07/09/2004

Date of the hearing

Information not available

Date of delivery

21/04/2005


References

Publication in the Official Journal

Applications: OJ C 158 from 05.07.2003, p.17 ; OJ C 200 from 23.08.2003, p.12

Judgment: OJ C 143 from 11.06.2005, p.9

Name of the parties

Novartis and Others

Notes on Academic Writings

Information not available



Procedural Analysis Information

Source of the question referred for a preliminary ruling

High Court of Justice (England & Wales), Chancery Division - United Kingdom

Subject-matter

  • Approximation of laws
  • Intellectual, industrial and commercial property
  • - Patents
  • External relations
  • - European Free Trade Association (EFTA)

Procedure and result

  • Reference for a preliminary ruling

Formation of the Court

deuxième chambre (Cour)

Judge-Rapporteur

Gulmann

Advocate General

Ruiz-Jarabo Colomer

Language(s) of the Case

  • English, French

Language(s) of the Opinion

  • Spanish